WO1999065928A8 - Polynucleotide population isolated from non-metastatic and metastatic breast tumor tissues - Google Patents

Polynucleotide population isolated from non-metastatic and metastatic breast tumor tissues

Info

Publication number
WO1999065928A8
WO1999065928A8 PCT/US1999/013647 US9913647W WO9965928A8 WO 1999065928 A8 WO1999065928 A8 WO 1999065928A8 US 9913647 W US9913647 W US 9913647W WO 9965928 A8 WO9965928 A8 WO 9965928A8
Authority
WO
WIPO (PCT)
Prior art keywords
metastatic
breast tumor
tumor tissues
population isolated
polynucleotide population
Prior art date
Application number
PCT/US1999/013647
Other languages
French (fr)
Other versions
WO1999065928A2 (en
Inventor
Bruce L Roberts
Srinivas Shankara
Original Assignee
Genzyme Corp
Bruce L Roberts
Srinivas Shankara
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genzyme Corp, Bruce L Roberts, Srinivas Shankara filed Critical Genzyme Corp
Priority to AU48241/99A priority Critical patent/AU4824199A/en
Publication of WO1999065928A2 publication Critical patent/WO1999065928A2/en
Publication of WO1999065928A8 publication Critical patent/WO1999065928A8/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/521—Chemokines
    • C07K14/523—Beta-chemokines, e.g. RANTES, I-309/TCA-3, MIP-1alpha, MIP-1beta/ACT-2/LD78/SCIF, MCP-1/MCAF, MCP-2, MCP-3, LDCF-1, LDCF-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
PCT/US1999/013647 1998-06-19 1999-06-17 Polynucleotide population isolated from non-metastatic and metastatic breast tumor tissues WO1999065928A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU48241/99A AU4824199A (en) 1998-06-19 1999-06-18 Polynucleotide population isolated from non-metastatic and metastatic breast tumor tissues

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
US8999798P 1998-06-19 1998-06-19
US8985398P 1998-06-19 1998-06-19
US9003998P 1998-06-19 1998-06-19
US9004198P 1998-06-19 1998-06-19
US9004098P 1998-06-19 1998-06-19
US60/089,853 1998-06-19
US60/090,040 1998-06-19
US60/089,997 1998-06-19
US60/090,039 1998-06-19
US60/090,041 1998-06-19

Publications (2)

Publication Number Publication Date
WO1999065928A2 WO1999065928A2 (en) 1999-12-23
WO1999065928A8 true WO1999065928A8 (en) 2000-06-22

Family

ID=27536549

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1999/013647 WO1999065928A2 (en) 1998-06-19 1999-06-17 Polynucleotide population isolated from non-metastatic and metastatic breast tumor tissues

Country Status (2)

Country Link
AU (1) AU4824199A (en)
WO (1) WO1999065928A2 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8927700B2 (en) 2009-08-21 2015-01-06 Gilead Biologics, Inc. Catalytic domains from lysyl oxidase and LOXL2
US9107935B2 (en) 2009-01-06 2015-08-18 Gilead Biologics, Inc. Chemotherapeutic methods and compositions
US9176139B2 (en) 2007-08-02 2015-11-03 Gilead Biologics, Inc. LOX and LOXL2 inhibitors and uses thereof

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7037663B2 (en) 1998-02-19 2006-05-02 Eastern Virginia Medical School Human zona pellucida protein 3 and uses thereof
EP1056858B1 (en) 1998-02-19 2004-12-08 Eastern Virginia Medical School RECOMBINANT ACTIVE HUMAN ZONA PELLUCIDA PROTEIN 3 (hZP3)
AU2001229768A1 (en) * 2000-01-28 2001-08-07 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services, The National Institutes Of Health Amplified genes at 17q23
WO2001061050A2 (en) * 2000-02-17 2001-08-23 Millennium Pharmaceuticals, Inc. Methods and compositions for the identification, assessment, prevention and therapy of human cancers
ATE387909T1 (en) 2000-05-31 2008-03-15 Novartis Vaccines & Diagnostic METHODS AND COMPOSITIONS FOR TREATING NEOPLASTIC DISEASES USING CHEMOTHERAPY AND RADIATION SENSITIZERS
US20040265804A1 (en) * 2000-07-25 2004-12-30 Oliver Von Stein Method for identifying metastatic tumor cells
US20030114410A1 (en) 2000-08-08 2003-06-19 Technion Research And Development Foundation Ltd. Pharmaceutical compositions and methods useful for modulating angiogenesis and inhibiting metastasis and tumor fibrosis
AU2002223950A1 (en) * 2000-09-20 2002-04-02 Qlt Inc. Cancer associated protein kinases and their uses
US6503756B1 (en) * 2000-09-22 2003-01-07 Isis Pharmaceuticals, Inc. Antisense modulation of syntaxin 4 interacting protein expression
DE10117381A1 (en) * 2001-04-06 2002-10-10 Wilex Biotechnology Gmbh Production of polyclonal, monospecific antibodies against the uPAR variants del4, del5 and del4 + 5 and their use for diagnostic and therapeutic purposes
EP1285970A3 (en) * 2001-06-26 2004-05-19 National Taiwan University Metastasis-associated genes
CA2456821A1 (en) 2001-08-02 2003-02-13 Trinity Biomedical Technology Corporation Human zona pellucida proteins and methods of their use in diagnosing male infertility
WO2003027276A2 (en) * 2001-09-24 2003-04-03 University Of Aarhus Novel compositions and methods for diagnosis and treatment of lymphoma and leukemia
AU2003268494A1 (en) * 2002-09-11 2004-04-30 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
DE10242319A1 (en) * 2002-09-12 2004-03-25 Avontec Gmbh New double-stranded oligonucleotides, useful for treating e.g. cardiovascular disease and arthritis, are decoys that lift inhibition of expression of endothelial nitric oxide synthase
US7846906B2 (en) 2003-02-28 2010-12-07 Isis Pharmaceuticals, Inc. Modulation of growth hormone receptor expression and insulin-like growth factor expression
US7803781B2 (en) * 2003-02-28 2010-09-28 Isis Pharmaceuticals, Inc. Modulation of growth hormone receptor expression and insulin-like growth factor expression
ATE506437T1 (en) 2003-05-21 2011-05-15 Andes Biotechnologies S A MARKERS FOR PRECANCER AND CANCER CELLS AND METHOD FOR DISTURBING CELL PROLIFERATION THEREOF
CN1833034B (en) 2003-06-20 2014-04-16 埃克斯魁恩公司 Probes, libraries and kits for analysis of mixtures of nucleic acids and methods for constructing the same
ES2289544T3 (en) * 2003-08-12 2008-02-01 Antisense Pharma Gmbh OLIGONUCLEOTIDO ANTISENTIDO TO INHIBIT THE INHIBITING ACTIVITY OF MELANOMA MIA.
JP5283265B2 (en) 2005-09-30 2013-09-04 アンチキャンサー インコーポレーテッド Methods for identifying markers of early human cancer, cancer progression and recurrence
US8188255B2 (en) 2006-10-20 2012-05-29 Exiqon A/S Human microRNAs associated with cancer
WO2008046911A2 (en) * 2006-10-20 2008-04-24 Exiqon A/S Novel human micrornas associated with cancer
CA2739788A1 (en) * 2008-10-07 2010-04-15 President And Fellows Of Harvard College Telomerase inhibitors that bind to the cr4-cr5 domain of the rna component of human telomerase and methods of use thereof
CA2777369A1 (en) * 2009-10-12 2011-04-21 Medimmune, Llc Quantification of ir-a and ir-b for tumor classification
CA2870288A1 (en) * 2012-04-10 2013-10-17 John J. Rossi Rna aptamers for therapeutic and diagnostic delivery to pancreatic cancer cells
EP2982756A1 (en) * 2014-08-04 2016-02-10 Berlin Cures Holding AG Aptamers for use against autoantibody-associated diseases

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9176139B2 (en) 2007-08-02 2015-11-03 Gilead Biologics, Inc. LOX and LOXL2 inhibitors and uses thereof
US9107935B2 (en) 2009-01-06 2015-08-18 Gilead Biologics, Inc. Chemotherapeutic methods and compositions
US9289447B2 (en) 2009-01-06 2016-03-22 Gilead Biologics, Inc. Chemotherapeutic methods and compositions
US8927700B2 (en) 2009-08-21 2015-01-06 Gilead Biologics, Inc. Catalytic domains from lysyl oxidase and LOXL2

Also Published As

Publication number Publication date
AU4824199A (en) 2000-01-05
WO1999065928A2 (en) 1999-12-23

Similar Documents

Publication Publication Date Title
WO1999065928A8 (en) Polynucleotide population isolated from non-metastatic and metastatic breast tumor tissues
EP0963207A4 (en) Il-12 gene therapy of tumors
AU1939200A (en) Electrochemical treatment of malignant tumors
EP1100886A4 (en) Tumor necrosis factor-gamma
EP1175616A4 (en) Methods for the diagnosis and treatment of metastatic prostate tumors
AU6257298A (en) Breast cancer specific gene 1
EP1077996A4 (en) HUMAN EDG3sb GENE
GB2318734B (en) Methods of preventing breast cancer
EP0821963A4 (en) Anticancer substance suppressing cancerous metastasis
AU2890199A (en) Gata-3-expression in human breast carcinoma
GB9805877D0 (en) Cancer
AU4369800A (en) Treatment of metastatic cancer through mts-1 gene
AU2342299A (en) Compositions and methods for detecting and treating breast cancer
AU4281200A (en) Immuno-adjuvant pdt treatment of metastatic tumors
EP0974652A4 (en) Cancerous metastasis-associated gene
AU4860299A (en) (zap-3) tumor associated genes and their uses
GB9804361D0 (en) Cancer treatment
AU2453399A (en) Bone cancer therapy
AU9336498A (en) New gene which is down-regulated in large intestine cancer
ZA992858B (en) Methods of preventing breast cancer.
GB9624800D0 (en) Methods of preventing breast cancer
AU3001899A (en) (zap-1) tumor associated genes and their uses
GB9804178D0 (en) Tumour suppressor gene
GB9818118D0 (en) Cancer gene
MXPA00006072A (en) Methods and compositions for inhibiting tumor cell growth.

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: C1

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: C1

Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

CFP Corrected version of a pamphlet front page
CR1 Correction of entry in section i

Free format text: PAT. BUL. 51/99 UNDER (81) ADD "AE, ZA"

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase